Worldwide: Pharma – Strong Year Ahead - Herbert Smith Freehills
Monday, 8 April 2024
After a relatively flat start, activity picked up in the second half of the year with a flurry of sizeable transactions announced including AbbVie's acquisitions of Cerevel and ImmunoGen...
|
||||
You Might Like |
||||
